Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2012 May 10;32(7):1624–1631. doi: 10.1161/ATVBAHA.112.246066

Table 2.

Tissue lipid content

A) INTESTINAL MUCOSA
Genotype TG TC FC CE PL FFA
Control-V 66.2±7.4a 49.7±7.4a 45.5±5.2a 4.3±2.3a 88.1±2.2a 25.11±1.96a
Control-T 74.0±14.5a 55.0±5.2a 46.9±3.3a 8.1±2.2a 102.4±5.9a 45.5±17.7a
MttpIKO-V 704.9±80.9b 76.1±5b 51.4±1.6a 27.7±3.8b 149.8±9.6b 192.8±43.1b
MttpIKO-T 704.6±45.9b 78.5±8.1b 55.3±4.7a 23.2±3.6b 169.5±9.3b 159.2±22.1b
B). HEPATIC
Genotype TG TC FC CE PL FFA
Control-V 71.3±10.3a 27.3±1.1a 10.7±1.3a 16.6±1.9a 99.1±5.5a 0.17±0.01a
Control-T 260.4±18.5b 17.6±1.9b 11.4±1.3a 6.1±0.9b 105.7±4.5a 0.34±0.03b
MttpIKO-V 39.5±6.3c 21.9±1.1b 9.6±1.3a 12.4±1.6ab 94.1±8.3a 0.14±0.01a
MttpIKO-T 246.7±21.7b 19.3±1.7b 9.1±0.8a 10.2±1.8ab 103.4±3.4a 0.27±0.02b

Control and MttpIKO mice (n=6–11) were treated either vehicle (V) or T0901317 (T). Tissue total cholesterol (TC), free cholesterol (FC), phospholipids (PL), and triglyceride (TG) were analyzed (Methods). Hepatic (A) and mucosal (B) lipid content was expressed as mean ±SE ug/mg protein, except FFA nmol/mg protein. The difference between values associated with different superscript letters for the parameters indicated in each vertical column is statistically significant (p<0.05).